At the headquarters in Vicenza, from 6th to 8th March, ASAlaser’s staff conducted a training of MLS® Laser Therapy and Hilterapia® for a delegation of Thai doctors from two prestigious hospitals, the Bangkok Dusit Medical Services Hospital and the Siriraj Hospital, which have integrated our therapies within their facilities. A partnership made possible thanks to the ongoing, 5-year-old collaboration with IMS: what better occasion to celebrate this milestone with a three-day targeted training. Among the doctors from the renowned hospitals, stands out the presence of Prof. Pradit Prateepavanich, author of the book ‘Myofascial Pain Syndrome’, in which he recorded his clinical experience with the M6 systems for MLS® Laser Therapy and Hiro 3.0 for Hilterapia®. During the training, a lot of time was dedicated to a hands-on session in order to refine the utilization techniques for these two devices, Hiro 3.0 and M6, and advanced utilization methods were explored to be able to optimize the results and significantly reduce the time of treatment. ‘At the end of the training,’ reported Giacomo Granozio, Area Manager, ‘the “Partner Performance Award” was handed to Panom Ammartmanee, Vice President of IMS, who said she was happy of the prize, and proud to collaborate with ASAlaser.’
A few days later, confirming the positive effects generated by the educational activity of our IMS partner in Thailand, the seminar ‘High Power Laser Therapy in musculoskeletal conditions based on evidence from clinical practice’ was held at the Naresuan University in Phitsanulok. To arouse great interest among the participants was the speech dedicated to the MLS® Laser Therapy given by Prof. Prasert, who hosted the entire seminar.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.